Akadeum Life Sciences
Akadeum’s patented microbubble technology represents a paradigm shift in therapeutic manufacturing, allowing scientists to process up to twice as many leukopaks in as little as one-third the time of traditional methods. This innovative platform was developed in order to give scientists an essential solution to workflow challenges across cell therapy.
Akadeum’s research use only kits work by floating targeted cells to the top of a sample, enabling minimal handling and healthier cells. Akadeum is pursuing B2B partnerships for applications in cell therapy in addition to its existing partnerships consisting of some of the largest corporations in the industry.